SNAP25-Related Syndrome
Table of contents
- What is SNAP25-related syndrome?
- Key Role
- Symptoms
- What causes SNAP25-related syndrome?
- Why does my child have a change in the SNAP25 gene?
- What are the chances that other family members or future children will have SNAP25-related syndrome?
- How many people have SNAP25-related syndrome?
- Do people who have SNAP25-related syndrome look different?
- How is SNAP25-related syndrome treated?
- Behavior and development concerns linked to SNAP25-related syndrome
- Medical and physical concerns linked to SNAP25-related syndrome
- Where can I find support and resources?
- Sources and References
SNAP25-related syndrome is also called developmental and epileptic encephalopathy 117 (DEE117). For this webpage, we will be using the name SNAP25-related syndrome to encompass the wide range of variants observed in the people identified.
What is SNAP25-related syndrome?
SNAP25-related syndrome happens when there are changes in the SNAP25 gene. These changes can keep the gene from working as it should.
Key Role
The SNAP25 gene plays a key role in the function and communication of brain cells.
Symptoms
Because the SNAP25 gene is important for brain activity, many people who have SNAP25-related syndrome have:
- Developmental delay
- Intellectual disability
- Seizures
- Autism spectrum disorder or features of autism
- Movement problems
- Speech impairment
- Low muscle tone
- Brain changes seen on magnetic resonance imaging (MRI)
- Vision issues
- Feeding challenges
What causes SNAP25-related syndrome?
SNAP25-related syndrome is a genetic condition, which means that it is caused by variants in genes. Our genes contain the instructions, or code, that tell our cells how to grow, develop, and work. Every child gets two copies of the SNAP25 gene: one copy from their mother’s egg, and one copy from their father’s sperm. In most cases, parents pass on exact copies of the gene to their child. But the process of creating the egg or sperm is not perfect. A change in the genetic code can lead to physical issues, developmental issues, or both.
Sometimes a spontaneous variant happens in the sperm, egg or after fertilization. When a brand new genetic variant happens in the genetic code is called a ‘de novo’ genetic variant. The child is usually the first in the family to have the genetic variant.
De novo variants can take place in any gene. We all have some de novo variants, most of which don’t affect our health. But because SNAP25 plays a key role in development, de novo variants in this gene can have a meaningful effect.
Research shows that SNAP25-related syndrome is often the result of a de novo variant in SNAP25. Many parents who have had their genes tested do not have the SNAP25 genetic variant found in their child who has the syndrome. In some cases, SNAP25-related syndrome happens because the genetic variant was passed down from a parent.
Autosomal dominant conditions
SNAP25-related syndrome is an autosomal dominant genetic condition. This means that when a person has the one damaging variant in SNAP25 they will likely have symptoms of SNAP25-related syndrome. For someone with an autosomal dominant genetic syndrome, every time they have a child there is a 50 percent chance they pass on the same genetic variant and a 50 percent chance they do not pass on the same genetic variant.
Autosomal Dominant Genetic Syndrome
Why does my child have a change in the SNAP25 gene?
No parent causes their child’s SNAP25-related syndrome. We know this because no parent has any control over the gene changes that they do or do not pass on to their children. Please keep in mind that nothing a parent does before or during the pregnancy causes this to happen. The gene change takes place on its own and cannot be predicted or stopped.
What are the chances that other family members or future children will have SNAP25-related syndrome?
Each family is different. A geneticist or genetic counselor can give you advice on the chance that this will happen again in your family.
The risk of having another child who has SNAP25-related syndrome depends on the genes of both biological parents.
- If neither biological parent has the same genetic variant found in their child, the chance of having another child who has the syndrome is on average 1 percent. This 1 percent chance is higher than the chance of the general population. The increase in risk is due to the very unlikely chance that more of the mother’s egg cells or the father’s sperm cells carry the same genetic variant.
- If one biological parent has the same genetic variant found in their child, the chance of having another child who has the syndrome is 50 percent.
For a symptom-free brother or sister of someone who has SNAP25-related syndrome, the sibling’s risk of having a child who has SNAP25-related syndrome depends on the sibling’s genes and their parents’ genes.
- If neither parent has the same genetic variant causing SNAP25-related syndrome, the symptom-free sibling has a nearly 0 percent chance of having a child who would inherit SNAP25-related syndrome.
- If one biological parent has the same genetic variant causing SNAP25-related syndrome, the symptom-free sibling has a 50 percent chance of also having the same genetic variant. If the symptom-free sibling has the same genetic variant, their chance of having a child who has the genetic variant is 50 percent.
For a person who has SNAP25-related syndrome, the risk of having a child who has the syndrome is about 50 percent.
How many people have SNAP25-related syndrome?
As of 2026, about 32 people with SNAP25-related syndrome have been identified in a medical clinic.
Do people who have SNAP25-related syndrome look different?
People with SNAP25-related syndrome may look different. Appearance can vary and can include, but is not limited to, these features:
- Vertical fold of skin that covers the inner corner of the eye
- Crowding of teeth
- Skin folds at the eyes, also called epicanthal folds
How is SNAP25-related syndrome treated?
Scientists and doctors have only just begun to study SNAP25-related syndrome. At this point, there are no medicines designed to treat the syndrome. A genetic diagnosis can help people decide on the best way to track the condition and manage therapies. Doctors can refer people to specialists for:
-
- Physical exams and brain studies
- Genetics consults
- Development and behavior studies
- Other issues, as needed
A developmental pediatrician, neurologist, or psychologist can follow progress over time and can help:
-
- Suggest the right therapies. This can include physical, occupational, speech, or behavioral therapy.
- Guide individualized education plans (IEPs).
Specialists advise that therapies for SNAP25-related syndrome should begin as early as possible, ideally before a child begins school.
If seizures happen, consult a neurologist. There are many types of seizures, and not all types are easy to spot. To learn more, you can refer to resources such as the Epilepsy Foundation’s website: www.epilepsy.com/learn/types-seizures.
This section includes a summary of information from major published articles. It highlights how many people have different symptoms. To learn more about the articles, see the Sources and References section of this guide.
Behavior and development concerns linked to SNAP25-related syndrome
Learning and Speech
All people with SNAP25-related syndrome had developmental delay or intellectual disability, and speech delay or impairment. About 1 in 3 people had a developmental regression associated with seizures in which they lost words that they previously attained.
- 25 out of 25 people had developmental delay (100 percent)
- 21 out of 21 people had intellectual disability (100 percent)
- 18 out of 19 people had speech delay or impairment (95 percent)
- 5 out of 19 people had a developmental regression (26 percent)
The severity of intellectual disability varied among people:
- 5 out of 20 people had mild intellectual disability (25 percent)
- 6 out of 20 people had moderate intellectual disability (30 percent)
- 5 out of 20 people had severe intellectual disability (25 percent)
- 4 out of 20 people had profound intellectual disability (20 percent)
Graphs
100%
80%
60%
40%
20%
0
Behavior
Some people with SNAP25-related syndrome had behavioral issues, such as features of autism and repetitive behaviors (stereotypic behavior).
- 3 out of 18 people had autism (17 percent)
- 4 out of 18 people had stereotypic behavior (22 percent)
Brain
Many people with SNAP25-related syndrome had seizures, including epileptic spasms, generalized seizures, focal seizures, and tonic-clonic seizures. The age of seizure onset occurred around 12 months, with a range of onset between birth to 12 years old. About 1 in 10 people developed refractory seizures. One-half of people were treated with more than 3 antiepileptic medications. Response to seizure medications was inconsistent.
- 19 out of 25 people had seizures (76 percent)
Seizure types varied among people:
- 7 out of 17 people had generalized or focal, bilateral tonic-clonic seizures (41 percent)
- 6 out of 17 people had absence-like seizures (35 percent)
- 5 out of 17 people had epileptic spasm seizures (29 percent)
- 4 out of 17 people had myoclonic, tonic, and atonic seizures (24 percent)
Graphs
100%
80%
60%
40%
20%
0
People with SNAP25-related syndrome had brain changes seen on magnetic resonance imaging (MRI), lower than average muscle tone (hypotonia), cortical visual impairment, and movement disorders, such as ataxia, dystonia, and tremor.
- 6 out of 22 people had brain changes seen on MRI (27 percent)
- 13 out of 21 people had hypotonia (63 percent)
- 6 out of 19 people had cortical visual impairment (32 percent)
- 8 out of 22 people had ataxia (36 percent)
- 4 out of 21 people had dystonia (19 percent)
- 2 out of 21 people had tremor (10 percent)
Graphs
100%
80%
60%
40%
20%
0
Medical and physical concerns linked to SNAP25-related syndrome
Growth
Some people with SNAP25-related syndrome had bilateral clubfeet, joint hypermobility, and hip dysplasia.
- 5 out of 21 people had bilateral clubfeet (24 percent)
- 4 out of 21 people had joint hypermobility (19 percent)
- 2 out of 21 people had hip dysplasia (10 percent)
Where can I find support and resources?
SNAP25 Foundation
The SNAP25 Foundation is dedicated to raising awareness of the genetic disorder caused by mutations in the gene Snap25, and working towards finding a cure.
Simons Searchlight
Simons Searchlight is an online international research program, building an ever growing natural history database, biorepository, and resource network of over 175 rare genetic neurodevelopmental disorders. By joining their community and sharing your experiences, you contribute to a growing database used by scientists worldwide to advance the understanding of your genetic condition. Through online surveys and optional blood sample collection, they gather valuable information to improve lives and drive scientific progress. Families like yours are the key to making meaningful progress. To register for Simons Searchlight, go to the Simons Searchlight website at www.simonssearchlight.org and click “Join Us.”
- Learn more about Simons Searchlight – www.simonssearchlight.org/frequently-asked-questions
- Simons Searchlight webpage with more information on SNAP25 – www.simonssearchlight.org/research/what-we-study/snap25
Sources and References
- Fernandes, I. F., Figueiredo, A. C., Parente Freixo, J., Dupont, J., & Carvalho, J. (2026). Episodic ataxia associated with synaptosomal-associated protein 25 (SNAP25) variant: Beyond epilepsy and developmental delay. Cureus, 18(1), e102586. doi:10.7759/cureus.102586
- Klöckner, C., Sticht, H., Zacher, P., Popp, B., Babcock, H. E., Bakker, D. P., Barwick, K., Bonfert, M. V., Bönnemann, C. G., … & Platzer, K. (2021). De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy. Genetics in Medicine, 23(4), 653-660. doi:10.1038/s41436-020-01020-w [correction: 10.1038/s41436-020-01090-w]
- Rohena, L., Neidich, J., Truitt Cho, M., Gonzalez, K. D., Tang, S., Devinsky, O., & Chung, W. K. (2013). Mutation in SNAP25 as a novel genetic cause of epilepsy and intellectual disability. Rare Diseases, 1, e26314. doi:10.4161/rdis.26314